Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents
1 other identifier
interventional
1,165
0 countries
N/A
Brief Summary
The purpose of this study was to determine whether messages about 1. relative risk of vaccination vs. other activities and 2. strength of doctor's recommendation influenced parental intention to get own child vaccinated against human papillomavirus (HPV) or Influenza.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 3, 2015
CompletedFirst Posted
Study publicly available on registry
February 6, 2015
CompletedOctober 31, 2023
October 1, 2023
Same day
February 3, 2015
October 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Willingness to vaccinate child with target vaccine
During survey administration, at approximately 15 minutes into the survey.
Study Arms (12)
Arm 1. HPV + Control + Control
NO INTERVENTIONHPV is target vaccine. No message regarding relative safety of vaccine; Provider provides brief routine recommendation for vaccination.
Arm 2. HPV + Control + Strong
EXPERIMENTALHPV is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination.
Arm 3. HPV + Control + Disclosure
EXPERIMENTALHPV is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Arm 4. HPV + Safety + Control
EXPERIMENTALHPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides brief routine recommendation for vaccination.
Arm 5. HPV + Safety + Strong
EXPERIMENTALHPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination.
Arm 6. HPV + Safety + Disclosure
EXPERIMENTALHPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Arm 7. Flu + Control + Control
NO INTERVENTIONFlu is target vaccine. No message regarding relative safety of vaccine; Provider provides brief routine recommendation for vaccination.
Arm 8. Flu + Control + Strong
EXPERIMENTALFlu is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination.
Arm 9. Flu + Control + Disclosure
EXPERIMENTALFlu is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Arm 10. Flu + Safety + Control
EXPERIMENTALFlu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides brief routine recommendation for vaccination.
Arm 11. Flu + Safety + Strong
EXPERIMENTALFlu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination.
Arm 12. Flu + Safety + Disclosure
EXPERIMENTALFlu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
Interventions
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Eligibility Criteria
You may qualify if:
- years of age or older
- Lives in United States
- Mother or female legal guardian of at least one child aged 9-13
- Able to understand English
- For HPV condition: Target child must not have received any doses of HPV vaccine
- For Flu condition: Target child must not have received the flu vaccine during the prior flu season
You may not qualify if:
- Under 18 years of age
- Not mother or female legal guardian of at least one child ages 9-13
- Not living in United States
- Not able to understand English and Spanish
- For HPV condition: Target child had already received at least 1 dose of the HPV vaccine
- For Flu condition: Target child received the influenza vaccine during the previous flu season
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory D Zimet, PhD
Indiana University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 3, 2015
First Posted
February 6, 2015
Study Start
August 1, 2014
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
October 31, 2023
Record last verified: 2023-10